Is maintenance therapy always necessary for patients with ulcerative colitis in remission?

Ardizzone, S; Petrillo, M; Imbesi, V; Cerutti, R; Bollani, S; Bianchi Porro, G

Ardizzone, S; Petrillo, M; Imbesi, V; Cerutti, R; Bollani, S; Bianchi Porro, G.

Affiliation

Ardizzone S; Gastrointestinal Unit, 'L. Sacco' Hospital, Milan, Italy.

Aliment Pharmacol Ther ; 13(3): 373-9, 1999 Mar.

Article in En | MEDLINE | ID: mdl-10102971

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Colitis, Ulcerative/drug therapy; Colitis, Ulcerative/prevention & control; Gastrointestinal Agents/therapeutic use; Mesalamine/therapeutic use; Sulfasalazine/therapeutic use; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Delayed-Action Preparations; Double-Blind Method; Female; Gastrointestinal Agents/administration & dosage; Gastrointestinal Agents/adverse effects; Humans; Male; Mesalamine/administration & dosage; Mesalamine/adverse effects; Middle Aged; Patient Compliance; Secondary Prevention; Sulfasalazine/administration & dosage; Sulfasalazine/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfasalazine / Gastrointestinal Agents / Colitis, Ulcerative / Anti-Inflammatory Agents, Non-Steroidal / Mesalamine Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 1999 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links